Glukoza Baxter (Glucose)

Glukoza Baxter is used in clinical settings where rapid delivery of glucose into the bloodstream is required.

• To provide an immediate source of energy for patients undergoing surgery or anesthesia.
• As part of fluid therapy for individuals with hypoglycemia or low blood glucose levels.
• During resuscitation efforts when oral intake is not possible.
• In metabolic testing protocols that require controlled intravenous glucose administration.
• To support nutritional needs of patients receiving total parenteral nutrition.
• For correction of electrolyte imbalances when combined with appropriate electrolyte solutions.

Glukoza Baxter may be associated with a range of adverse reactions, most of which are related to the intravenous administration of a carbohydrate solution. Reactions can vary in severity and may depend on the infusion rate, patient condition, and concurrent therapies.

Common

• Mild hyperglycemia (temporary rise in blood glucose).
• Local irritation or pain at the infusion site.
• Nausea or mild vomiting.
• Headache.
• Transient increase in serum osmolality.
• Mild flushing or warmth sensation.
• Mild dizziness or light‑headedness.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reaction such as rash, itching, or anaphylaxis.
• Electrolyte disturbances, particularly hyponatremia.
• Hypotension due to rapid infusion.
• Hyperosmolar coma in extreme cases.

When using Glukoza Baxter, clinicians should observe specific precautions to minimize risks and ensure safe administration, and follow institutional protocols.

• Verify patient blood glucose level before initiating infusion.
• Adjust infusion rate according to individual tolerance and clinical guidelines.
• Avoid rapid bolus administration unless specifically indicated.
• Monitor vital signs and serum electrolytes during and after infusion.
• Use aseptic technique to prevent contamination of the IV solution.
• Consider contraindications such as severe hyperglycemia or known glucose intolerance.
• Store the product according to manufacturer’s temperature recommendations.

Glukoza Baxter can interact with other intravenous solutions or medications, influencing glucose balance or electrolyte status.

Avoid

• Concurrent infusion of high‑concentration dextrose solutions without adjusting total carbohydrate load.
• Co‑administration with insulin infusions without appropriate dose adjustments.
• Mixing with calcium‑containing solutions that may precipitate.
• Infusion together with sodium bicarbonate solutions, which may cause precipitation of glucose.

Use with caution

• Simultaneous administration with diuretics that affect fluid and electrolyte balance.
• Concurrent use of beta‑blockers, which can mask symptoms of hypoglycemia.
• Infusion alongside potassium supplements; monitor serum potassium levels.
• Administration with glucocorticoids, as they may increase blood glucose levels.
• Concurrent infusion with other glucose‑containing solutions; monitor total carbohydrate intake.